Cellorgane® Multi-Complex 3G Formula 10 Páncreas

Pancreatic Function

Problem

With age, pancreas function decreases progressively, mainly by excessive consumption of sugars, generating increased insulin resistance

Uses

Malabsorption syndrome, type II diabetes mellitus, metabolic syndrome and Hepatic impairment.

Solution

The contribution of cellular cytokines and growth factors in embryonic extracts has a refreshing and revitalizing effect at the cellular level, which increases the specific functionality of the organ to be treated.
Antioxidant enzymes neutralize free radicals, thereby reducing damage from oxidative stress.

Composition

Oral CELLORGANE 10 Each 500-mg enteric coated tablet contains: Opotherapic cell extracts: Pancreas 50%, embryonic ectoderm 10%, Thymus 10%, Placenta 10%; Antioxidant enzyme complex: Superoxide dismutase, glutathione peroxidase, glutathione reductase, glutathione transferase; Maltodextrin 20% and stabilizers.

Action Mechanisms

Formula components reach the cells directly or indirectly, in the case of oral products, by bloodstream, and are selectively incorporated into the cells through various means of cellular transport.
It works by revitalizing the pancreas, improving pancreatic function.

Contraindications

  • Allergies to animal proteins.
  • Allergy to any of its components.
  • Pregnancy and lactation.

Posology

Malabsorption syndrome, type II diabetes mellitus, metabolic syndrome and Hepatic impairment.
Orally: Two tablets in the morning and 2 at night, for at least six months.
The tablets are taken in the morning on an empty stomach and at night before dinner (30 minutes before meals).

Note:
The dose may be increased according to the clinical picture of the patient and the physician's discretion; the results depend on the completion of treatment.

Adjuvant treatment with:

Antihypertensive and heart failure
  • Calcium antagonists: Nifedipine
  • ACE inhibitors: Enalapril, Captopril
  • ARB-II: losartan, candesartan
  • Beta-blockers: Atenolol, Metoprolol, Carvedilol, Bisoprolol
  • Thiazide diuretics: Hydrochlorothiazide, chlorthalidone, indapamide, xipamide, Ameride (thiazide & K+ saver)
Hypoglycemic
  • Biguanides: Metformin
  • Inhibitors of alpha-glucosidase: Acarbose
  • Sulfonylureas: glibenclamide, glimepiride, glyburide and Tolazamide
  • Injectable drugs (like GLP-1): Sitagliptin, Saxagliptin, and linagliptin
  • Meglitinides: Repaglinide, nateglinide
  • SGLT2 Inhibitors: Dapagliflozin
  • Thiazolidinediones: Pioglitazone
  • DPP IV inhibitors: Sitagliptin and vildagliptin
  • Injectable insulin
Diuretics
  • Loop diuretics: Furosemide, Amiloride
  • Thiazide and analogues: IDEM (above)
  • K + Savers: Spironolactone
  • Osmotic: Mannitol
Statins

Selective, competitive inhibitors of HMG-CoA reductase: atorvastatin, simvastatin, pravastatin

Coronary vasodilators
  • Antianginal: Calcium antagonists - Nifedipine
  • Competitive antagonist of beta 1 and beta 2 adrenergic receptors: Propranolol
Heart failure Digitalis: Digoxin
Venous insufficiency
  • Venotonic and vasculoprotective drugs: Diosmin, Hidrosmin, Horse Chestnut Seed
Antidepressants
  • Selective serotonin reuptake inhibitors (SSRI): paroxetine, sertraline, fluoxetine, citalopram, escitalopram
  • Serotonin–norepinephrine reuptake inhibitors (SNRIs): venlafaxine, duloxetine, Desvenlafaxine
  • NaSSA: Mirtazapine
  • Tricyclic: amitriptyline, clomipramine, imipramine
  • MAOIs: Moclobemide
  • Serotonin–norepinephrine reuptake inhibitor (SNRI): Reboxetine
  • Dopamine-norepinephrine reuptake inhibitor (DNRI): Bupropion
Anti-anemic Iron
Renal impairment Recombinant erythropoietin, Furosemide, Amino Acids
Erectile dysfunction (ED) cyclic GMP-specific phosphodiesterase type 5 (PDE5): Sildenafil
© 2017 Biocell Ultravital. Privacy
Like Us on Facebook Follow Us on Twitter